Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-02 Tax Withholding | 2021-11-03 4:16 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 62 | $1.98 | 15,136 (Direct) | View |
| 2021-10-04 Tax Withholding | 2021-10-05 6:40 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 62 | $2.01 | 15,198 (Direct) | View |
| 2021-09-02 Tax Withholding | 2021-09-03 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 61 | $1.81 | 15,260 (Direct) | View |
| 2021-08-03 Tax Withholding | 2021-08-04 5:45 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 63 | $2.4 | 15,321 (Direct) | View |
| 2021-07-02 Tax Withholding | 2021-07-06 4:31 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 154 | $3.7 | 15,384 (Direct) | View |
| 2021-06-04 Tax Withholding | 2021-06-07 5:01 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 155 | $4.19 | 15,538 (Direct) | View |
| 2021-05-04 Tax Withholding | 2021-05-05 9:56 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 191 | $4.13 | 15,693 (Direct) | View |
| 2021-04-08 Tax Withholding | 2021-04-09 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 192 | $4.94 | 15,884 (Direct) | View |
| 2021-03-03 Tax Withholding | 2021-03-05 4:31 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 192 | $5.46 | 16,076 (Direct) | View |
| 2021-02-02 Tax Withholding | 2021-02-03 9:53 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 988 | $6.34 | 26,268 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 9:53 pm | N/A 2031-02-01 | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 10,000 | $0 | 26,268 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-05 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 115 | $4.85 | 17,256 (Direct) | View |
| 2020-12-07 Tax Withholding | 2020-12-08 8:17 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 91 | $3.76 | 17,371 (Direct) | View |
| 2020-11-02 Tax Withholding | 2020-11-03 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 96 | $3.51 | 17,462 (Direct) | View |
| 2020-10-02 Tax Withholding | 2020-10-05 5:56 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 98 | $3.88 | 17,558 (Direct) | View |
| 2020-09-02 Tax Withholding | 2020-09-03 5:31 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 97 | $3.94 | 17,656 (Direct) | View |
| 2020-08-04 Tax Withholding | 2020-08-05 5:11 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 92 | $4.11 | 17,753 (Direct) | View |
| 2020-07-02 Tax Withholding | 2020-07-06 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development | 94 | $4.82 | 17,845 (Direct) | View |